tetramethylpyrazine has been researched along with Benign Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, P; Hao, X; Liu, X; Xu, H; Zhan, P; Zou, J | 1 |
| Cheng, L; Fan, Q; Hao, T; Li, D; Lv, H; Ma, H; Peng, J; Shao, M; Zhao, C; Zong, X | 1 |
| Chu, F; Gong, Y; Gu, S; Lei, H; Li, G; Wang, M; Wang, P; Xu, B; Xu, K; Xu, X; Zhang, H; Zhang, Y | 1 |
1 review(s) available for tetramethylpyrazine and Benign Neoplasms
| Article | Year |
|---|---|
Recent progress in the structural modification and pharmacological activities of ligustrazine derivatives.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Bacteria; Cardiovascular Diseases; Humans; Inflammation; Molecular Structure; Neoplasms; Neuroprotective Agents; Pyrazines | 2018 |
2 other study(ies) available for tetramethylpyrazine and Benign Neoplasms
| Article | Year |
|---|---|
Synthesis of folate‑chitosan nanoparticles loaded with ligustrazine to target folate receptor positive cancer cells.
Topics: A549 Cells; Chitosan; Drug Liberation; Endocytosis; Folate Receptors, GPI-Anchored; Folic Acid; Humans; Hydrogen-Ion Concentration; MCF-7 Cells; Nanoparticles; Neoplasms; Proton Magnetic Resonance Spectroscopy; Pyrazines; Spectrophotometry, Infrared; Time Factors | 2017 |
Amino acid derivatives of ligustrazine-oleanolic acid as new cytotoxic agents.
Topics: Antineoplastic Agents; Apoptosis; Cytotoxins; HeLa Cells; Hep G2 Cells; Humans; Neoplasms; Oleanolic Acid; Pyrazines; Structure-Activity Relationship; Vasodilator Agents | 2014 |